Status:

COMPLETED

Weight Reduction Intervention for Breast Cancer Survivors

Lead Sponsor:

University of California, San Diego

Collaborating Sponsors:

American Cancer Society, Inc.

San Diego State University

Conditions:

Breast Cancer

Eligibility:

FEMALE

18-90 years

Phase:

NA

Brief Summary

Overweight or obesity is an established negative prognostic factor in both premenopausal and postmenopausal breast cancer. Several mechanisms have been proposed to explain the adverse effect of excess...

Detailed Description

Background: Overweight or obesity is an established negative prognostic factor in both premenopausal and postmenopausal breast cancer. Adverse effects of adiposity on prognosis may be explained by eff...

Eligibility Criteria

Inclusion

  • Diagnosed with Stage I-IIIA breast cancer within the previous 10 years
  • Have completed initial treatments (i.e., surgery, adjuvant chemotherapy, radiation therapy)
  • Have initial BMI \>25.0 kg/m2
  • A minimum of 15 kg over ideal weight
  • Willingness and ability to attend group meetings and to maintain contact with the investigators for 18 months
  • Ability to provide dietary and exercise data by telephone at prescribed intervals.

Exclusion

  • Inability to participate in physical activity because of severe disability

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

253 Patients enrolled

Trial Details

Trial ID

NCT00774371

Start Date

January 1 2005

End Date

December 1 2009

Last Update

November 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Moores UCSD Cancer Center

La Jolla, California, United States, 92093